Phe855 Rrmm News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Phe855 Rrmm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Phe855 Rrmm Today - Breaking & Trending Today

PHE855 Continues to Show High, Durable Responses in R/R Multiple Myeloma

Published: June 3, 2023

Now that positive phase 1 results have been reported for PHE855, a phase 2 study of PHE855 is currently underway in patients with relapsed and refractory multiple myeloma.

Source: targetedonc.com

Related Topics:

United StatesDana Farber Cancer InstituteAdams SperlingRelapsed Or Refractory Multiple MyelomaPhase 1 StudyCar ProductCart CellsChimeric Antigen Receptort Cell TherapyCart Cell TherapyPhe855 RrmmDoi 10 1200 Jco 2023 41 16 Suppl 8004Fart Products